92057-32-4 Usage
Thiazole derivative
A compound that is derived from the five-membered heterocyclic ring system, thiazole, which consists of four carbon atoms and one nitrogen atom.
Nitrophenyl group
A functional group consisting of a phenyl ring (a six-membered carbon ring with hydrogen atoms) attached to a nitro group (-NO2), which is known to have various biological activities.
Carboxylic acid moiety
A functional group containing a carbonyl group (C=O) and a hydroxyl group (-OH) bonded to the same carbon atom, which can participate in various chemical reactions and is important for the compound's biological activity.
Potential applications in pharmaceutical and medicinal chemistry
The compound may have uses in the development of drugs and treatments due to its diverse biological activities.
Diverse biological activities
The compound may exhibit a range of biological effects, such as antimicrobial, antifungal, or anti-inflammatory properties, making it a potential candidate for drug development.
Need for further research and studies
More investigation is required to fully understand the pharmacological properties and potential applications of 2-(3-nitro-phenyl)-thiazole-4-carboxylic acid.
Check Digit Verification of cas no
The CAS Registry Mumber 92057-32-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,0,5 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 92057-32:
(7*9)+(6*2)+(5*0)+(4*5)+(3*7)+(2*3)+(1*2)=124
124 % 10 = 4
So 92057-32-4 is a valid CAS Registry Number.
92057-32-4Relevant articles and documents
Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: Synthesis, in vitro characterization, and x-ray crystallography
Wright, Stephen W.,Carlo, Anthony A.,Carty, Maynard D.,Danley, Dennis E.,Hageman, David L.,Karam, George A.,Levy, Carolyn B.,Mansour, Mahmoud N.,Mathiowetz, Alan M.,McClure, Lester D.,Nestor, Nestor B.,McPherson, R. Kirk,Pandit, Jayvardhan,Pustilnik, Leslie R.,Schulte, Gayle K.,Soeller, Walter C.,Treadway, Judith L.,Wan, Ing-Kae,Bauer, Paul H.
, p. 3865 - 3877 (2007/10/03)
The synthesis and in vitro structure-activity relationships (SAR) of a novel series of anilinoquinazolines as allosteric inhibitors of fructose-1,6-bisphosphatase (F16Bpase) are reported. The compounds have a different SAR as inhibitors of F16Bpase than a
